Rchr
J-GLOBAL ID：202401016282832215
Update date: Apr. 16, 2025 Takeda June
Takeda June
- 2022 - 2025 PDX models of rare hematopoietic malignancies for novel cancer therapies
-
中川 正宏, 稲垣 良作, 黒田 隆, 南谷 泰仁, 趙 蘭英, 越智 陽太郎, 本村 公則, 昆 彩奈, 岡崎 幸治, 竹田 淳恵, et al. 単一細胞マルチオミクス解析によるクローン性造血の病態解明. 日本血液学会学術集会. 2024. 86回. O2-3
-
中川 正宏, 稲垣 良作, 黒田 隆, 南谷 泰仁, 趙 蘭英, 越智 陽太郎, 本村 公則, 昆 彩奈, 岡崎 幸治, 竹田 淳恵, et al. 単一細胞マルチオミクス解析によるクローン性造血の病態解明(Distinct pathogenesis of clonal hematopoiesis revealed by single-cell multi-omics sequencing). 日本癌学会総会記事. 2024. 83回. IS10-6
-
Naokazu Nakamura, Nao Yamamoto, Tadakazu Kondo, Mayumi Matsumoto, Ryo Ikunari, Tomomi Sakai, Yasuhiro Tanaka, Hiroko Tsunemine, June Takeda, Junya Kanda, et al. Sustained remission after cord blood transplantation for breast cancer with lung metastases and myelodysplastic syndrome. International Journal of Hematology. 2024. 119. 6. 762-767
-
Naokazu Nakamura, Ryo Ikunari, Yasuhiro Tanaka, Hiroko Tsunemine, June Takeda, Nobuyoshi Arima. Pathogenic <i>TNFRSF13B</i> Variant in an Adult Japanese Patient with Common Variable Immunodeficiency. Internal Medicine. 2024
-
中川 正宏, 稲垣 良作, 黒田 隆, 南谷 泰仁, 趙 蘭英, 越智 陽太郎, 本村 公則, 竹田 淳恵, 戚 星星, 岡崎 幸治, et al. 単一細胞マルチオミクス解析によるクローン造血の病態解明. 日本血液学会学術集会. 2023. 85回. 287-287
ｍore...-
依田 成玄, 森下 大輔, 越智 陽太郎, 水谷 明生, 森 拓人, 竹田 淳恵, 戸崎 浩和, 佐藤 義彦, 南谷 泰仁, 牧島 秀樹, et al. 骨髄性腫瘍を標的とした新規スプライシングモジュレーターCTX-712の開発(CTX-712, a novel splicing modulator targeting myeloid neoplasms). 日本癌学会総会記事. 2022. 81回. E-2027
-
Rurika Okuda, Yasuhito Nannya, Yotaro Ochi, Kazuhisa Chonabayashi, Maria Creignou, Hideki Makishima, June Takeda, Ayana Kon, Satoru Miyano, Hiroshi Handa, et al. Distinct ethnic, clinical, and genetic characteristics of der(1;7) in myelodysplastic syndromes. CANCER SCIENCE. 2021. 112. 310-310
-
Masahiro Nakagawa, Ryosaku Inagaki, Yasuhito Nannya, Lanying Zhao, Yotaro Ochi, June Takeda, Xingxing Qi, Akinori Yoda, Ayana Kon, Nobuyuki Kakiuchi, et al. Early Clonal evolution of myeloid malignancies. CANCER SCIENCE. 2021. 112. 969-969
-
June Takeda, Kenichi Yoshida, Akinori Yoda, Yasuhito Nannya, Masahiro Nakagawa, Yotaro Ochi, Ayana Kon, Tetsuichi Yoshizato, Yusuke Shiozawa, Yuichi Shiraishi, et al. JAK STAT Pathway is a Promising Therapeutic target in Acute Erythroid Leukemia. CANCER SCIENCE. 2021. 112. 453-453
-
Akinori Yoda, Daisuke Morishita, Akio Mizutani, Yotaro Ochi, Hirokazu Tozaki, Yoshihiko Satoh, June Takeda, Yasuhito Nannya, Hideki Makishima, Hiroshi Miyake, et al. CTX-712, a novel CLK inhibitor targeting myeloid neoplasms with SRSF2 mutation. CANCER SCIENCE. 2021. 112. 250-250
ｍore...